You are here

Human AECs in Metabolic Disease Treatment

In a new STEM CELLS Translational Medicine review article, researchers led by Toshio Miki (Nihon University School of Medicine, Tokyo, Japan) discuss practical issues associated with clinical trials of stem cell‐based cell therapies for congenital metabolic disorders, which focused on maple syrup urine disease. Takano et al. hope that their article will help expedite the translation of a promising amniotic stem cell into clinical trials and elicit similar discussions pertaining to other stem cell types and diseases beyond congenital metabolic disorders.